Merlin Labs stock
Private-market facts for current and former Merlin Labs employees researching their stock.
Overview
Merlin Labs develops autonomous piloting systems for aircraft, starting with military cargo planes, to enable fully autonomous fixed-wing flight.
Selling Merlin Labs shares
Why shareholders consider selling
Shareholders in Merlin Labs may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Merlin Labs does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.
Can you sell Merlin Labs stock?
Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Aerospace & Defense sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Merlin Labs shares would be outlined in the holder's equity agreement or the company's governing documents.
What affects the value of Merlin Labs shares?
The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Aerospace & Defense market conditions, and any recent private-market transaction activity. Data points such as the company's Series B round can help frame expectations, though they do not guarantee a transaction price.
What should holders check before selling
- The type of security held (common shares, preferred, options, RSUs)
- Whether the equity is fully vested and, for options, whether it has been exercised
- Any transfer restrictions, lock-up provisions, or company approval requirements
- Estimated net proceeds after applicable taxes and transaction fees
- Whether partial liquidity — selling a portion rather than the full position — may be a better fit
Tools for Merlin Labs shareholders
Exploring equity in Merlin Labs often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.
Latest funding round
Merlin Labs most recently raised a Series B round . Total funding raised to date is approximately $120M.
Lead investors in this round include GV (Google Ventures) and Snowpoint Ventures.
Founders & company background
Merlin Labs was founded in 2018 by Matt George and is headquartered in Boston, MA.
Investors
Industry
Similar private companies
Latest Merlin Labs news
Frequently asked questions
- Is Merlin Labs still a private company?
- Yes, Merlin Labs is currently a private company.
- What is Merlin Labs's latest funding round?
- Merlin Labs's most recent known round is Series B.
- What is Merlin Labs's valuation?
- Merlin Labs's valuation has not been publicly disclosed.
- Who are the investors in Merlin Labs?
- Notable investors include GV (Google Ventures), Snowpoint Ventures.
- Can I sell my Merlin Labs stock?
- Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Merlin Labs stock can help you evaluate your options.
Related pages
Last verified: 2026-04-13 · Merlin Labs data compiled from funding disclosures, investor announcements, corporate filings, and public records.
Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.